Search - tctmd.com

Displaying 1 - 6 of 6

Sort: Relevancy | Date

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Conference News AHA 2014

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

Yael L. Maxwell

November 16, 2014

Presentation TCT 2012

If You Want the Truth, Randomize!

Presenter: Robert Harrington

October 24, 2012

Presentation TCT 2012

In Vivo Characterization of Bioresorbable Vascular Scaffold Strut Interfaces Using Optical Coherence Tomography with Gaussian Line Spread Function Analysis

Presenter: Alexander Sheehy, Juan Luis Guti?rrez-Chico, Roberto Diletti, James P Oberhauser, Thierry Glauser, Joel Harrington, Mary Beth Kossuth, Richard J Rapoza, Yoshinobu Onuma, Patrick W. Serruys

January 03, 2012

Advertisement

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

DAPT Study Shows Benefit of Long-Term Treatment After DES Implantation

If You Want the Truth, Randomize!

In Vivo Characterization of Bioresorbable Vascular Scaffold Strut Interfaces Using Optical Coherence Tomography with Gaussian Line Spread Function Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content